The Technology

Required Steps for TVAX Immmunotherapy

  1. The surgical specimen is saved for vaccine manufacture.
  2. Irradiation of the cancer cells is completed so that they are unable to multiply.
  3. Creation of the vaccination begins at the TVAX production facility. The cancer cells are combined with the immunological adjuvant GM-CSF and TB syringes are prepared.
  4. Administration of vaccine to stimulate an immune response. The immune response produces high numbers of “killer” cell precursors within the body.
  5. The “killer” T-cell precursors are collected from the blood, taken to the TVAX facility and are manufactured into “killer” T-cells.
  6. The “killer T-cells are transfused into the bloodstream so that they can travel to sites of cancer growth and destroy cancer cells.

Steps 4 through 6 are repeated to invigorate and support the awakened immune system

Treatment Time 10 weeks

TVAX lab image TVAX lab image TVAX lab image TVAX lab image TVAX lab image TVAX lab image TVAX lab image TVAX lab image TVAX lab image TVAX lab image